Ajanta Pharma Limited announces the receipt of final approval for Duloxetine Hydrochloride Delayed Release Capsules from US FDA. It is a bioequivalent generic version of Cymbalta®1 Delayed Release Capsules. Company will be launching the product shortly in 3 strengths, 20 mg, 30 mg and 60 mg strengths capsules. Duloxetine Hydrochloride Delayed Release Capsules is part of an ever growing portfolio of products that Ajanta has developed for the US market.